No Data
No Data
Entrada Therapeutics(TRDA.US) Officer Sells US$26,282.1 in Common Stock
$Entrada Therapeutics(TRDA.US)$ Officer WENTWORTH KORY JAMES sold 1,758 shares of common stock on Jul 8, 2024 at an average price of $14.95 for a total value of $26,282.1.Source: Announcement What
Entrada Therapeutics Is Maintained at Buy by HC Wainwright & Co.
Entrada Therapeutics Is Maintained at Buy by HC Wainwright & Co.
Entrada Therapeutics Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 06/25/2024 26.4% HC Wainwright & Co. $20 → $18 Maintains Buy 03/18/2024 40.45% HC Wainwright & Co. → $20 R
H.C. Wainwright Maintains Entrada Therapeutics(TRDA.US) With Buy Rating, Cuts Target Price to $18
H.C. Wainwright analyst Ram Selvaraju maintains $Entrada Therapeutics(TRDA.US)$ with a buy rating, and adjusts the target price from $20 to $18.According to TipRanks data, the analyst has a success ra
Express News | Entrada Therapeutics, Inc. : H.c. Wainwright Cuts Target Price to $18 From $20
Express News | Entrada to Fund Clinical Trials With Offering Proceeds